Fang Cheng
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 5
- Internal Medicine top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 3
- Pharmacology top 10%
- Clinical Psychology top 10%
-
- Chronic Myeloid Leukemia Treatments 8
-
- Chronic Lymphocytic Leukemia Research 7
-
- Eosinophilic Disorders and Syndromes 4
-
- Pharmacological Effects and Toxicity Studies 4
-
- PI3K/AKT/mTOR signaling in cancer 3
- Natural product bioactivities and synthesis 2
- Journals
- Cancer (1 paper)Free Radical Biology and Medicine (1 paper)Carbohydrate Polymers (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fang Cheng
44 papers receiving 859 citations
Peers
Comparison fields: 5 of 133
- Transplantation 37
- Internal Medicine 49
- Infectious Diseases 163
- Pharmacology 51
- Clinical Psychology 113
Countries citing papers authored by Fang Cheng
This map shows the geographic impact of Fang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Cheng more than expected).
Fields of papers citing papers by Fang Cheng
This network shows the impact of papers produced by Fang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Cheng. The network helps show where Fang Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fang Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 27 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 41 | |
| 15 | 2021 | 15 | |
| 16 | 2020 | 151 | |
| 17 | 2020 | 88 | |
| 18 | 2020 | 34 | |
| 19 | 2019 | 85 | |
| 20 | 2018 | 12 |
About Fang Cheng
Fang Cheng is a scholar working on Transplantation, Hematology and Genetics, having authored 48 papers that have together received 878 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Renal Transplantation Outcomes and Treatments (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), COVID-19 Clinical Research Studies (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Transplantation (37 citations), Internal Medicine (49 citations) and Infectious Diseases (163 citations). Fang Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yu Zhang, Fang Zeng, Kaiping Wang, Zheng Cui, Cheng Peng, Ruoqi Zhang, Yihui Liu, Chen Shi, Chuanjie Guo and Miao Wang. Their work appears in journals such as Cancer, Free Radical Biology and Medicine and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.